Report overview
This report contains market size and forecasts of IV and Oral Iron Drugs in Global, including the following market information:
Global IV and Oral Iron Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global IV and Oral Iron Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Iron Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IV and Oral Iron Drugs include Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi and Shield Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the IV and Oral Iron Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IV and Oral Iron Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global IV and Oral Iron Drugs Market Segment Percentages, by Type, 2021 (%)
Oral Iron Drug
IVIron Drugs
Global IV and Oral Iron Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global IV and Oral Iron Drugs Market Segment Percentages, by Application, 2021 (%)
Nephrology
OBGYN
Surgeries
Gastroenterology
Oncology
Heart failure (HF)
Global IV and Oral Iron Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global IV and Oral Iron Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IV and Oral Iron Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies IV and Oral Iron Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Daiichi Sankyo Company
Vifor Pharma
Akebia Therapeutics
Allergan
AMAG Pharmaceuticals
AOP Orphan Pharmaceuticals
Pharmacosmos
Sanofi
Shield Therapeutics
AZAD Pharma
Cirondrugs
MEDICE
Pfizer
Salveo Lifecare
Sunny Pharmaceutical
